Power asymmetry in CMB polarization maps from PLANCK : a local variance analysis

A persistent signal of power asymmetry on opposite hemispheres of CMB sky was seen in full-sky temperature measurements made so far. This asymmetry was seen in microwave sky from WMAP as well as PLANCK satellites, and calls for attention the larger question of \emph{statistical isotropy}, one of the foundational principles of modern cosmology. In this work we present an analysis of polarized CMB maps from PLANCK 2015 full mission data. We apply the local variance estimator on low resolution $E-$mode maps from PLANCK 2015 polarization \texttt{Commander} solution. We find a significant hemispherical power asymmetry in polarization data on large angular scales, at the level of $\sim 2.6-3.9\%$ depending on the galactic mask, and the circular disc radius used for computing local variance maps. However the direction is found to be pointing broadly towards CMB kinetic dipole direction. Precise measurements of CMB polarization in future will shed light on this apparent discrepancy in the anisotropy axis seen in temperature and polarized CMB sky, and likely influence of systematics on our findings.Comment: 21 pages, 10 figures, 3 table

Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure

Acute liver failure is a critical condition characterized by global hepatocyte death and often time needs a liver transplantation. Such treatment is largely limited by donor organ shortage. Stem cell therapy offers a promising option to patients with acute liver failure. Yet, therapeutic efficacy and feasibility are hindered by delivery route and storage instability of live cell products. We fabricated a nanoparticle that carries the beneficial regenerative factors from mesenchymal stem cells and further coated it with the membranes of red blood cells to increase blood stability. Unlike uncoated nanoparticles, these particles promote liver cell proliferation <i>in vitro</i> and have lower internalization by macrophage cells. After intravenous delivery, these artificial stem cell analogs are able to remain in the liver and mitigate carbon tetrachloride-induced liver failure in a mouse model, as gauged by histology and liver function test. Our technology provides an innovative and off-the-shelf strategy to treat liver failure